Navigation Links
US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022
Date:1/15/2014

TORONTO, Jan. 15, 2014 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States and European transcatheter embolization and occlusion (TEO) device markets will expand moderately through 2022, with embolization particles representing one of the fastest-growing segments. In particular, increasing interest in drug-eluting beads (DEBs) and radioembolization spheres in interventional oncology has fueled rapid growth of these markets.

The European radioembolization sphere market will be further boosted by expansion in the United Kingdom a result of the National Health Service's (NHS) Commissioning through Evaluation program, which will evaluate radioembolization as a treatment for liver cancer and fund its use in a small number of patients. While the NHS has yet to decide on widespread coverage of radioembolization, the program will improve awareness of the procedure and encourage other countries to consider expanding reimbursement.

In both the US and Europe, there is considerable competitive activity in the embolization particle market. A recent acquisition made by BTG in the radioembolization space and the US launch of a new DEB product, ONCOZENE, by CeloNova BioSciences have reshaped the competitive landscape. Competitive dynamics are also shifting in the peripheral vascular (PV) plug space. Although St. Jude Medical's AMPLATZER line has historically held a monopoly, in 2013, Reverse Medical's Micro Vascular Plug gained US and European approval, and EndoShape's Medusa Vascular gained approval in the US. ArtVentive Medical Group's EOS device, which is increasingly being used in Europe in the emerging pelvic congestion syndrome indication, will also likely enter the US market in the near future.

"While St. Jude Medical dominated the PV plug market in 2013, we'll start to see the impact of new entrants in 2014," said MRG Senior Analyst Sean Messenger. "These smaller, innovative PV plug companies represent attractive acquisition targets for PV coil companies that want to offer comprehensive product portfolios in the TEO space."

Millennium Research Group's US Markets for Transcatheter Embolization and Occlusion Devices 2014 and European Markets for Transcatheter Embolization and Occlusion Devices 2014 reports include unit, procedure, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for interventional neuroradiology (INR) embolization coils, INR coiling-assist devices, INR flow-diverting devices, PV embolization coils, PV plugs, embolization particles, liquid embolics and accessory devices in the United States, France, Germany, Italy, Spain and the United Kingdom. Supplemental country coverage is also available for Austria, Belgium, the Czech Republic, Denmark, Finland, Greece, Hungary, the Netherlands, Norway, Poland, Portugal, Romania, Sweden, Switzerland and Ukraine, as well as in aggregate for the rest of the European countries.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CorMedix Awarded European Patent for Neutrolin
2. The US and European Video and High-Tech Hardware Device Markets Will Reach a Combined Value of Over $4.6 Billion by 2022
3. Oramed Receives Patent in the European Union for the Oral Delivery of Insulin
4. Lumena Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation in the European Union for LUM001 in Four Rare Liver Diseases
5. RXi Pharmaceuticals Corporation and Ethicor Ltd. Announce the Signing of a Distribution Agreement for RXI-109 in the European Union under the "Specials" Provision
6. MGB Biopharma Adds its Support to European Antibiotic Awareness Day
7. Pi2 Solutions Presents on Pharmacovigilance Literature Screening at Major European Risk Management Meeting
8. European Home Healthcare Market Report 2013-2017: Products, Services & Telehealth
9. European Interventional Cardiology Device Market Will Remain Stable Through 2022 at Over $1.2 Billion
10. HighPoint Solutions and InnoPeritus Partner to Provide Unprecedented Consultative Services in the European Life Sciences Market
11. US and European Regulators Accept for Review OMS302 Marketing Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ALBANY, New York , February 23, 2017 /PRNewswire/ ... Global Cardiac Holter Monitor Market are GE Healthcare, Koninklijke ... share of about 48% in the global market in ... are the two key factors assessed to be aiding ... Transparency Market Research states that the players in the ...
(Date:2/23/2017)... On Wednesday, February 22, 2017, US ... of nine sectors finished the trading sessions in green, four ... Major US indices were also mixed at the close of ... slightly down by 0.09%; the Dow Jones Industrial Average edged ... closed at 2,362.82, down 0.11%. This Thursday morning, Stock-Callers.com looks ...
(Date:2/23/2017)... 2017   SeraCare Life Sciences , a ... diagnostics manufacturers and clinical laboratories, is announcing an ... NGS-Based Tests" to be hosted by GenomeWeb ... Eastern Standard Time (US). The goal ... for improved performance and global standardization in the ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... 2017 , ... Congratulations to Head Over Heels’ elite gymnast ... Ms. Esparza qualified into this prestigious status after winning the Vault, Floor, ... Nevada. Frida is one of approximately 25 gymnasts in the nation who earns ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Department of Justice jointly issued a letter to withdraw previous guidance ... with their gender identity. The guidance issued in May 2016 by the Obama ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... clinician-based audience, will be participating in Rare Disease Day events, hosted by the ... addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will be ...
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Hamlin ... to announce that they are sponsoring a raffle. Throughout the month of February, patients ... will receive a gift card for a dinner for two at the Cheesecake Factory. ...
(Date:2/23/2017)... ... 23, 2017 , ... On April 13, 2017, The ... “Doping in Sport: How the Culture Might Change,” in conjunction with Pepperdine ... will be held at Pepperdine University in Malibu, California. , Sir Philip Craven, ...
Breaking Medicine News(10 mins):